| ASSET | MONTH | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | February 2017 | 10,426.32% |
Datasea (DTSS) | February 2017 | 1,000% |
Duos Technologies (DUOT) | February 2017 | 500% |
Worksport (WKSP) | February 2017 | 390% |
Panbela Therapeutics (PBLA) | February 2017 | 155.89% |
Quantum Computing (QUBT) | February 2017 | 153.33% |
Ryvyl (RVYL) | February 2017 | 150% |
Atlas Lithium Corporation Common Stock (ATLX) | February 2017 | 142.72% |
Castellum (CTM) | February 2017 | 133.05% |
Aehr Test Systems (AEHR) | February 2017 | 122.03% |
Renovaro Biosciences (RENB) | February 2017 | 121.43% |
Esperion Therapeutics (ESPR) | February 2017 | 113.81% |
Trxade (MEDS) | February 2017 | 112.5% |
Scienture (SCNX) | February 2017 | 112.5% |
JX Luxventure (JXJT) | February 2017 | 110.44% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | February 2017 | 107.89% |
Pulse Biosciences (PLSE) | February 2017 | 103.64% |
Avid Bioservices (CDMO) | February 2017 | 101.67% |
Netcapital (NCPL) | February 2017 | 100% |
Biovie (BIVI) | February 2017 | 93.51% |
Inotiv (NOTV) | February 2017 | 90.59% |
Galectin Therapeutics (GALT) | February 2017 | 90% |
Gravity (GRVY) | February 2017 | 88.47% |
Checkpoint Therapeutics (CKPT) | February 2017 | 87.5% |
Aspira Womens Health (AWH) | February 2017 | 83% |
